Hyperinsulinemia in a normal population as a predictor of non—insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The barilla factory revisited

doi:10.1016/S0026-0495(99)90195-6

Metabolism

Volume 48, Issue 8, August 1999, Pages 989-994

https://doi.org/10.1016/S0026-0495(99)90195-6 Get rights and content

Abstract

The study was initiated to evaluate the ability of hyperinsulinemia (as a surrogate measure of insulin resistance) to predict the development in a previously healthy population of three putative outcomes of this abnormality—glucose intolerance, hypertension, and coronary heart disease (CHD). The study involved defining the incidence at which these changes occurred between 1981 and 1993 to 1996 in 647 individuals who were free of any disease when initially studied. The study population consisted of approximately 90% of the subjects evaluated in 1981, divided into quartiles on the basis of the plasma insulin response to a glucose challenge as determined in 1981. The results indicated that the 25% of the population with the highest insulin response in 1981 had significant (P < .001) increases in the incidence of impaired glucose tolerance (IGT) or type 2 diabetes (eightfold), hypertension (twofold), or CHD (threefold). Furthermore, the ability of hyperinsulinemia to predict the three clinical endpoints was independent of differences in age, gender, or body mass index (BMI). Finally, if CHD is considered the clinical endpoint, multiple logistic regression analysis indicates that the values for plasma triglyceride (TG) and mean arterial blood pressure ([MAP] as measured in 1981) also predict the development of CHD. These results indicate that the untoward clinical effects of insulin resistance and/or compensatory hyperinsulinemia, glucose intolerance, hypertension, and CHD clearly can develop in less than 15 years.

References (32)

JH Fuller et al.
Coronary-heart-disease risk and impaired glucose tolerance: The Whitehall Study
Lancet
(1980)
H Blackburn
Classification of the electrocardiogram for population studies: Minnesota code
J Electrocardiol
(1969)
FS Facchini et al.
Enhanced sympathetic nervous system activity—The link between insulin resistance, hyperinsulinemia, and heart rate
Am J Hypertens
(1996)
I Zavaroni et al.
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance
N Engl J Med
(1989)
O Vaccaro et al.
Relationship of postload plasma glucose to mortality with 19-yr follow-up
Diabetes Care
(1992)
K Pyorala
Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland
Diabetes Care
(1979)
J-P Després et al.
Hyperinsulinemia as an independent risk factor for ischemic heart disease
N Engl J Med
(1996)
WB Kannel
Importance of hypertension as a major risk factor in cardiovascular disease
LA Carlson et al.
Risk factors for myocardial infarction in the Stockholm Prospective Study: A 14 year follow-up focusing on the role of plasma triglycerides and cholesterol
Acta Med Scand
(1979)
WP Castelli et al.
HDL cholesterol and other lipids in coronary heart disease
Circulation
(1977)

NE Miller et al.

The Tromso Heart Study: High-density lipoprotein and coronary artery disease

GM Reaven

Role of insulin resistance in human disease

Diabetes

(1988)

E Ferrannini et al.

Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome

Diabetologia

(1991)

K Landin et al.

Elevated fibrinogen and plasminogen activator (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

J Intern Med

(1990)

SM Haffner et al.

Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

JAMA

(1990)

GM Reaven et al.

Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles

J Clin Invest

(1993)

Cited by (175)

CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy
2021, Nutrition, Metabolism and Cardiovascular Diseases
CA.ME.LI.A (CArdiovascular risks, MEtabolic syndrome, LIver and Autoimmune disease) is a cross-sectional, epidemiological study performed between 2009–2011 in Abbiategrasso (Milan, Italy) to estimate the prevalence of cardiovascular risk factors, metabolic syndrome, liver and autoimmune diseases in the general adult population. This report focuses on the description and presentation of baseline characteristics of the population.
Citizens were randomly selected from the city electoral registers (n = 30903), yielding a sample of 2554 subjects (M = 1257, F = 1297; age, 47 ± 15 yrs; range 18–77 yrs). Men had higher prevalence of overweight or obesity (60.8% vs 41.6%; p < 0.0001) and greater thickness of visceral adipose tissue (40 ± 19 vs 27 ± 17 mm; p < 0.0001); no gender difference was found in subcutaneous adipose tissue thickness. Men also showed higher levels of serum triglycerides, γ-GT, fasting blood glucose, insulin and Homa-IR Index, while HDL, CRP, and prevalence of elevated (>5.0 mg/L) CRP were lower. Compared to normal weight men, risk-ratio (RR) of CRP elevation was 1.32 (ns) in overweight and 2.68 (p < 0.0001) in obese subjects. The corresponding figures in females were 2.68 (p < 0.0001) and 5.18 (p < 0.0001). Metabolic syndrome was more frequent in men (32.7% vs 14.5%; RR: 2.24, p < 0.0001). Interadventitia common carotid artery diameter was higher in men and increased with age and BMI.
The present study reports on the overall characteristics of a large population from Northern Italy. It aims to identify the associations among cardiovascular risk factors to prevent their development and progression, improve healthy lifestyle and identify subjects liable to pharmacological interventions.
Associations between omega-6 polyunsaturated fatty acids, hyperinsulinemia and incident diabetes by race/ethnicity: The Multi-Ethnic Study of Atherosclerosis
2020, Clinical Nutrition
Citation Excerpt :
Hyperinsulinemia is linked to many chronic diseases, including type 2 diabetes (T2D) [1].
Omega-6 polyunsaturated fatty acids (PUFAs) have been shown to relate to insulin resistance and type 2 diabetes (T2D), but influence of race/ethnicity has not been investigated. The aim of this study was to determine whether omega-6 PUFAs, and estimated desaturase enzyme activity, are associated with fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and incident T2D, and whether associations differ by race/ethnicity.
This study was conducted in the Multi-Ethnic Study of Atherosclerosis (MESA) (N = 6282). Associations between baseline plasma phospholipid fatty acids (LA, Linoleic Acid; GLA, γ-linoleic acid; DGLA, Dihomo-γ-linolenic acid; AA, arachidonic acid; D5D, delta-5 desaturase; D6D, delta-6 desaturase), fasting glucose, insulin, and HOMA-IR [(fasting insulin – fasting glucose)/22.5] were evaluated using linear regression. Associations between omega-6 PUFAs (N = 5508 after excluding diabetics at baseline) and T2D incidence were assessed using Cox proportional hazards regression. Analyses were replicated/stratified by race/ethnicity (White, Black, Chinese, Hispanic) and tests for interaction were assessed by inclusion of a cross-product term in models.
In fully adjusted models, insulin and HOMA-IR were positively associated with LA (insulin: 0.213 per SD, p = 0.01; HOMA-IR: 0.252 per SD, p < 0.001), GLA (insulin: 0.010 per SD, p < 0.001; HOMA-IR: 0.006 per SD, p < 0.001), DGLA (insulin: 0.279 per SD, p < 0.001; HOMA-IR: 0.175 per SD, p < 0.001) and D6D activity (insulin: 0.001 per SD, p < 0.001; HOMA-IR: 0.006 per SD, p < 0.001), and inversely associated with AA (insulin −0.272 per SD, p < 0.001; HOMA-IR: −0.125 per SD, p = 0.03) and D5D activity (insulin: −0.530 per SD, p < 0.001; HOMA-IR: −0.322 per SD, p < 0.001), while weak or no associations were observed with fasting glucose, and associations appeared to differ by race/ethnicity. After accounting for HOMA-IR at baseline, LA was inversely (HR: 0.87, p = 0.003) and DGLA (HR: 1.17, p < 0.001) and AA (HR: 1.15, p = 0.001) were positively associated with T2D in the overall population, but associations were attenuated or no longer present when stratified by race/ethnicity (P-interaction >0.05).
Results confirm previous reports that omega-6 PUFAs are associated with hyperinsulinemia. Findings suggest omega-6 PUFAs are more likely markers of hyperinsulinemia rather than a protective/risk factor for T2D and indicate racial/ethnic differences in associations, but further research is needed to confirm findings.
Physical exercise in chronic diseases
2018, Nutrition and Skeletal Muscle
This review provides the reader with the up-to-date evidence-based basis for prescribing exercise as medicine in the treatment of patients with metabolic conditions (adiposity, hyperlipidemia, metabolic syndrome, type 2 diabetes, type 1 diabetes), cardiovascular conditions (hypertension, coronary heart disease, heart failure, cerebral apoplexy, and intermittent claudication), pulmonary diseases (chronic obstructive pulmonary disease, asthma), and cancer.
Relationship between simple markers of insulin resistance and coronary artery calcification
2017, Journal of Clinical Lipidology
Insulin resistance in apparently healthy persons is associated with a cluster of metabolic abnormalities that promote coronary atherosclerosis. Identifying these individuals before manifest disease would provide useful clinical information.
We hypothesized that combining 2 simple markers of insulin resistance, prediabetes (PreDM) and triglyceride (TG) concentration ≥150 mg/dL, would identify apparently healthy persons with adverse cardiometabolic risk profiles and increased coronary artery calcium (CAC) compared with those with neither or only 1 abnormality.
A cross-sectional analysis was performed using data from 25,886 apparently healthy individuals (18,453 men and 7433 women) evaluated at the Cooper Clinic from 1998 to 2015. Participants were divided into those with a normal fasting glucose concentrations (<100 mg/dL = normal fasting glucose) or PreDM (fasting plasma glucose ≥100 and <126 mg/dL) and further subdivided into those with a plasma TG concentration <150 or ≥150 mg/dL. These 4 groups were compared on the basis of multiple coronary artery disease risk factors and the presence of CAC determined during their evaluation.
Participants with PreDM and a TG concentration ≥150 mg/dL had a significantly more adverse coronary artery disease risk profile than individuals with either abnormality or only 1 abnormality (PreDM or TG concentration ≥150 mg/dL). Furthermore, the odds of detectable CAC were higher in participants with PreDM and a TG ≥ 150 mg/dL than in participants with neither or only 1 abnormality.
The presence of 2 markers of insulin resistance, PreDM and TG concentration ≥150 mg/dL, is associated with increased cardiometabolic risk and detectable CAC within a population of apparently healthy individuals.
Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals
2017, Nutrition, Metabolism and Cardiovascular Diseases
Insulin resistance is associated with a cluster of abnormalities that increase cardiovascular disease (CVD). Several indices have been proposed to identify individuals who are insulin resistant, and thereby at increased CVD risk. The aim of this study was to compare the abilities of 3 indices to accomplish that goal: 1) plasma triglyceride × glucose index (TG × G); 2) plasma triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C); and 3) Metabolic Syndrome (MetS).
In a population sample of 723 individuals (486 women and 237 men, 50 ± 16 and 51 ± 16 years old, respectively), baseline demographic and metabolic variables known to increase CVD risk and incident CVD were compared among individuals defined as high vs. low risk by: TG × G; TG/HDL-C; or MetS. CVD risk profiles appeared comparable in high risk subjects, irrespective of criteria. Crude incidence of CVD events was increased in high risk subjects: 12.2 vs. 5.3% subjects/10 years, p = 0.005 defined by TG/HDL-C; 13.4 vs. 5.3% subjects/10 years, p = 0.002 defined by TG × G; and 13.4% vs. 4.5% of subjects/10 years, p < 0.001 in subjects with the MetS. The area under the ROC curves to predict CVD were similar, 0.66 vs. 0.67 for TG/HDL-C and TG × G, respectively. However, when adjusted by age, sex and multiple covariates, hazard ratios for incident CVD were significantly increased in high risk patients classified by either TG/HDL-C ratio (2.18, p = 0.021) or MetS (1.93, p = 0.037), but not by TG × G index (1.72, p = 0.087).
Although the 3 indices identify CVD risk comparably, the TG × G index seems somewhat less effective at predicting CVD.
Clinical correlates of plasma insulin levels over the life course and association with incident type 2 diabetes: The Framingham Heart Study
2022, BMJ Open Diabetes Research and Care

View all citing articles on Scopus

^☆: Supported by research grants from University and Scientific Research, Italian Ministry, and the National Institutes of Health (HL-08506).

View full text

Hyperinsulinemia in a normal population as a predictor of non—insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The barilla factory revisited☆

Abstract

Lancet

J Electrocardiol

Am J Hypertens

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

N Engl J Med

Relationship of postload plasma glucose to mortality with 19-yr follow-up

Diabetes Care

Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland

Diabetes Care

Hyperinsulinemia as an independent risk factor for ischemic heart disease